ATI-052 Phase 1b POC Results Update | Aclaris Therapeutics, Inc.

View all events »

ATI-052 Phase 1b POC Results Update

Oct 27, 2026
8:00 AM EDT

Click here for webcast

Supporting Materials

ATI-052 POC Trial results in AD and Asthma 1.1 MB